RGD DISEASE ONTOLOGY - ANNOTATIONS
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
Term: Neisseriaceae Infections
Accession: DOID:9008538
browse the term
Definition: Infections with bacteria of the family NEISSERIACEAE.
Synonyms: exact_synonym: Neisseriaceae Infection
primary_id: MESH:D016870 ; RDO:0005693
xref: EFO:1001377
G
C8a
complement C8 alpha chain
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:9759902
NCBI chr 5:124,812,131...124,866,631
Ensembl chr 5:119,583,174...119,637,754
G
C8b
complement C8 beta chain
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:8098723
NCBI chr 5:124,763,974...124,801,522
Ensembl chr 5:119,535,146...119,572,565
G
Cd40
CD40 molecule
ISO
RGD
PMID:19202131
RGD:5132273
NCBI chr 3:174,209,113...174,224,592
Ensembl chr 3:153,790,449...153,805,534
G
Cfd
complement factor D
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11457876
NCBI chr 7:10,463,773...10,465,496
Ensembl chr 7:9,813,150...9,815,053
G
Ace
angiotensin I converting enzyme
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11956052
NCBI chr10:91,410,129...91,430,246
Ensembl chr10:90,910,316...90,931,131
G
Add1
adducin 1
ISO
DNA:missense mutation:cds:p.G460W (human)
RGD
PMID:18679149
RGD:5147999
NCBI chr14:80,333,242...80,401,641
Ensembl chr14:76,108,654...76,167,182
G
C3
complement C3
severity
ISO
RGD
PMID:3491693
RGD:11041157
NCBI chr 9:2,174,412...2,201,339
Ensembl chr 9:2,087,437...2,114,429
G
Cfb
complement factor B
severity
ISO
RGD
PMID:3491693
RGD:11041157
NCBI chr20:3,975,271...3,981,138
Ensembl chr20:3,951,474...3,976,505
G
Cfd
complement factor D
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16527897
NCBI chr 7:10,463,773...10,465,496
Ensembl chr 7:9,813,150...9,815,053
G
Cfh
complement factor H
treatment exacerbates
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:20694013 PMID:25143339 PMID:19047406
RGD:11041174 , RGD:108019051
NCBI chr13:54,063,079...54,164,523
Ensembl chr13:51,511,828...51,613,838
G
Cpb2
carboxypeptidase B2
ISO
RGD
PMID:14717966
RGD:1598478
NCBI chr15:56,967,128...57,015,964
Ensembl chr15:50,557,717...50,606,556
G
Fcgr2a
Fc gamma receptor 2A
severity
ISO
associated with complement deficiency;DNA:missense mutation:cds:p.H131R (human) DNA:polymorphism:cds:p.H131R (human)
RGD
PMID:10792385 PMID:11812402
RGD:5147980 , RGD:11040998
NCBI chr13:85,813,516...85,830,269
Ensembl chr13:83,280,784...83,295,967
G
Il4
interleukin 4
susceptibility
ISO
DNA:SNP:promoter:-524C>T(human)
RGD
PMID:20016407
RGD:14696700
NCBI chr10:38,272,003...38,277,549
Ensembl chr10:37,771,203...37,776,750
G
C9
complement C9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:9570574
NCBI chr 2:57,300,510...57,348,759
Ensembl chr 2:55,572,992...55,621,338
G
Cd46
CD46 molecule
ISO
RGD
PMID:12869763
RGD:6483466
NCBI chr13:109,104,122...109,134,903
Ensembl chr13:106,574,858...106,660,445
G
Cfp
complement factor properdin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:8530058 PMID:10909851
NCBI chr X:3,715,551...3,721,113
Ensembl chr X:1,161,979...1,167,573
G
Marco
macrophage receptor with collagenous structure
IEP
protein:increased expression:sub-cortical, meninges, astrocyte
RGD
PMID:21299846
RGD:41412190
NCBI chr13:34,169,011...34,210,340
Ensembl chr13:31,616,278...31,648,521
G
Mmp13
matrix metallopeptidase 13
IEP
RGD
PMID:10430840
RGD:8547971
NCBI chr 8:12,782,829...12,793,108
Ensembl chr 8:4,497,960...4,508,239
G
Mmp9
matrix metallopeptidase 9
IEP
RGD
PMID:10430840
RGD:8547971
NCBI chr 3:174,103,474...174,111,434
Ensembl chr 3:153,683,858...153,692,120
G
Nod2
nucleotide-binding oligomerization domain containing 2
susceptibility
ISO
DNA:SNP,haplotype: :SNP8(human)
RGD
PMID:23691182
RGD:7800668
NCBI chr19:34,555,832...34,596,281
Ensembl chr19:18,382,439...18,417,177
G
Slc11a1
solute carrier family 11 member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16597321
NCBI chr 9:83,406,327...83,417,252
Ensembl chr 9:75,957,316...75,968,101
G
Tlr2
toll-like receptor 2
susceptibility
ISO
DNA:haplotype: :2477G>A(rs5743708)(human)
RGD
PMID:23691182
RGD:7800668
NCBI chr 2:171,499,189...171,504,831
Ensembl chr 2:169,197,419...169,206,630
G
Tlr4
toll-like receptor 4
susceptibility
ISO
DNA:SNP,haplotype: :896A>G(rs4986790)(human)
RGD
PMID:23691182
RGD:7800668
NCBI chr 5:85,161,247...85,174,882
Ensembl chr 5:80,145,826...80,159,628
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all